Summary[1]
 | |
| Type | Public |
|---|---|
| |
| Industry | Medical Appliances & Equipment |
| Founded | 1995 |
| Headquarters | Sunnyvale, California, U.S. |
Key people |
|
| Products | da Vinci Surgical System |
| Revenue |  US$6.22 billion (2022) |
 US$1.58 billion (2022) | |
| US$1.32 billion (2022) | |
| Total assets | US$12.97 billion (2022) |
| Total equity | US$11.11 billion (2022) |
Number of employees | 12,120 (December 2022) |
| Website | intuitive |
| Footnotes / references [2] | |
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Operations
- Da Vinci
- Ion
- Hub
- My Intuitive
Market
Main Competition
CRM Surgical
CRM Surgical, formerly known as Cambridge Medical Robotics, is a private UK-based medical technology company that specializes in developing the Versius robotic surgical system. Versius is designed to assist surgeons in performing a wide range of laparoscopic procedures with enhanced precision and flexibility. The modular and portable design of the system allows for easy setup and adaptability in various surgical environments. With 3D high-definition visualization, haptic feedback, and versatile instruments, Versius aims to make robotic-assisted surgery more accessible. Recently, the company achieved a significant milestone by raising an impressive $1 billion in funds, leading to a valuation of over $3 billion, reflecting strong investor confidence in its technology and potential for growth in the medical robotics industry. As a private company, CRM Surgical operates independently and is not publicly traded on any stock exchange.[3]
- Med Robotics
- Verb Surgical
- Auris Health
- Masor Robotics
- Asensus Surgical
Key Individuals
Gary S. Guthart, Ph.D. Chief Executive Officer and Member of the Board of Directors
Gary S. Guthart, Ph.D., is the CEO of Intuitive and a Board of Directors member since 2010, leveraging over 25 years of experience in medical, engineering, scientific, and management fields. He joined Intuitive in 1996 as a control systems analyst, steadily rising to become President and COO. Prior to Intuitive, Guthart contributed to foundational technology for computer-enhanced surgery at SRI International and worked on algorithms for large-scale system control. He holds a B.S. in engineering from the University of California, Berkeley, and earned M.S. and Ph.D. degrees in engineering science from the California Institute of Technology. Additionally, Guthart serves on the Boards of Directors for Illumina and the Silicon Valley Leadership Group.
Dave Rosa President
Dave Rosa is the President of Intuitive, where he oversees the core business and drives product and commercial excellence. He joined Intuitive in 1996 and has held various senior leadership positions, including Executive Vice President and Chief Strategy and Growth Officer. Rosa is a strong advocate for da Vinci technology and has been involved in its development since the beginning. Prior to Intuitive, he contributed to the development of trans-esophageal transducers for Acuson Corporation. Rosa also serves on the board of directors for Kardium and as chairman of the board of the joint venture between Intuitive Surgical and Fosun Pharma. He holds a B.S. in mechanical engineering from California Polytechnic University at San Luis Obispo and an M.S. in mechanical engineering from Stanford University, and he holds multiple patents.
Dr. Myriam J. Curet, M.D., F.A.C.S., Executive Vice President and Chief Medical Officer
Myriam J. Curet, M.D., F.A.C.S., is the Executive Vice President and Chief Medical Officer for Intuitive, a role she has held since November 2017. With a background in general surgery and a distinguished medical career spanning over two decades, Dr. Curet joined Intuitive in 2005 as Chief Medical Advisor, later becoming Senior Vice President and Chief Medical Officer in 2014. She received her M.D. from Harvard Medical School and completed her general surgery residency program at the University of Chicago. Throughout her tenure at Intuitive, Dr. Curet has played a crucial role in shaping the company's medical strategy and advancing the use of robotic-assisted surgery across various fields. Her commitment to innovation and patient-centered care has solidified Intuitive's position as a global leader in the medical robotics industry.
Jamie Samath, Chief Financial Officer
Jamie Samath is the Chief Financial Officer at Intuitive, where he has held various finance-related roles since joining the company in 2013, including Senior Vice President of Finance, Corporate Controller, and Principal Accounting Officer. Before his tenure at Intuitive, Samath served in finance roles at Atmel Corporation, including Vice President of Finance and Corporate Controller. He also worked in various finance positions at National Semiconductor. Samath holds a B.A. in business studies from London Metropolitan University and is a certified public accountant.
Brian Miller, Ph.D., Executive Vice President and Chief Digital Officer
Brian Miller, Ph.D., is the Executive Vice President and Chief Digital Officer at Intuitive, responsible for overseeing the company's digital business strategy, solutions, operations, product management, infrastructure, privacy, security, and network operations. With over 20 years of experience in robotics and digital technology, Miller has been instrumental in creating clinical and operational value for customers and driving new business value for the company. His career at Intuitive began with the merger of Computer Motion in 2003, where he had developed software for early robotic surgical systems. Throughout his tenure, Miller has held various engineering roles, earning patents for key innovations in robotic surgical systems and surgeon training simulations. He holds a B.S. in electrical and computer engineering from Iowa State University, an M.S., and Ph.D. in mechanical engineering from Northwestern University, with a focus on haptic interfaces and robotics, and has also completed the Advanced Management Program at Harvard Business School.
Bob De Santis, Executive Vice President and Chief Strategy and Corporate Operations Officer
Bob DeSantis is the Executive Vice President and Chief Strategy and Corporate Operations Officer at Intuitive, where he oversees strategic planning and corporate operational management for the business. Having joined Intuitive in 2013, DeSantis has held various leadership roles, including Vice President for instruments & accessories New Product Introduction and Chief Product Officer, where he led global teams responsible for developing and manufacturing the company's robotic platforms and related functions. With a background in mechanical engineering, DeSantis has been involved in the research and development of laparoscopic technologies, contributing to the advancement of minimally invasive surgery. He holds a B.S. and M.S. in mechanical engineering from the State University of New York, Buffalo, and has a certificate in innovation management from the Massachusetts Institute of Technology.
Gary Loeb, General Counsel and Chief Compliance Officer
Gary Loeb is the General Counsel and Chief Compliance Officer at Intuitive, leading a global organization responsible for legal, compliance, and corporate governance. With extensive experience in patent strategy, collaborations, licensing, clinical and medical affairs, ethics, legal operations, compliance, and regulatory matters, Loeb previously held positions in intellectual property and litigation at Genentech and served as General Counsel for various medical diagnostic and therapeutic firms, including Mammoth Biosciences. He holds a B.S. in biological sciences and a B.A. in English from Stanford University and obtained his J.D. from Columbia Law School.
Kara Andersen Reiter, Intuitive Senior Vice President, Litigation, Privacy, and Employment Law
Kara Andersen Reiter is the Senior Vice President of Litigation, Privacy, and Employment Law at Intuitive. She joined the company in 2015 as Assistant General Counsel and later held positions as Senior Vice President, General Counsel, and Chief Compliance Officer. With a background in litigation and experience in the medical device industry, Andersen Reiter has been a valuable asset to Intuitive. She earned her J.D. from UCLA School of Law and her B.A. from Brown University. Additionally, as a Fulbright scholar, she obtained a D.E.A. (a master's-level degree) in family law from the Universite de Lyon III after completing her law degree.
Marshall L. Mohr, Executive Vice President, Global Business Services
Marshall L. Mohr is the Executive Vice President of Global Business Services at Intuitive. He joined the company in March 2006 as Senior Vice President and Chief Financial Officer, later becoming Executive Vice President and Chief Financial Officer in June 2018. Prior to Intuitive, Mohr held positions as Vice President and CFO of Adaptec, Inc., and as an audit partner with PricewaterhouseCoopers, where he managed the firm's technology industry group in the west region and led the accounting and audit advisory practice in Silicon Valley. He currently serves on the board of directors of Plantronics, Inc. (Poly) and Pacific Biosciences of California, Inc., and is a board member of the joint venture between Intuitive Surgical and Fosun Pharma in Shanghai, China. Mohr holds a B.B.A. in accounting and finance from Western Michigan University.
Majority Stake Holders
| Name | Equities | % | Valuation |
|---|---|---|---|
| The Vanguard Group, Inc. | 17,800,947 | 5.080 % | 6 087 M $ |
| T. Rowe Price Associates, Inc. (Investment Management) | 11,603,541 | 3.312 % | 3 968 M $ |
| Geode Capital Management LLC | 6,117,781 | 1.746 % | 2 092 M $ |
| Fidelity Management & Research Co. LLC | 5,913,266 | 1.688 % | 2 022 M $ |
| JPMorgan Investment Management, Inc. | 4,528,044 | 1.292 % | 1 548 M $ |
| Capital Research & Management Co. (World Investors) | 4,376,155 | 1.249 % | 1 496 M $ |
| AllianceBernstein LP | 4,003,505 | 1.143 % | 1 369 M $ |
| Edgewood Management LLC | 3,888,946 | 1.110 % | 1 330 M $ |
| Norges Bank Investment Management | 3,469,428 | 0.9901 % | 1 186 M $ |
| BlackRock Advisors LLC | 3,033,180 | 0.8656 % | 1 037 M $ |